BSECompany Update6d ago · 14 Aug 2026, 12:01 pm
Please find enclosed herewith the copies of newspaper advertisement published regarding the extract of statement of Un-audited Standalone and Consolidated Financial Results of the Company ....
Bliss GVS Pharma Ltd · 506197
✦ AI SummaryResults
Bliss GVS Pharma Ltd has published the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
de723762-78e9-45d6-986f-90f0e490fbee.pdf
View document text
August 14, 2026
To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Limited BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197
Dear Sir/Madam,
Subject: Intimation of publication of Unaudited Standalone and Consolidated Financial
Results for the quarter ended June 30, 2026
According to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, please find enclosed herewith the copies of the newspaper
advertisement published regarding the extract of the statement of un-audited standalone and
consolidated financial results for the quarter ended June 30, 2026, along with the Quick
Response Code (“QR Code”) and weblink of the Company to access complete Financial
Results in ‘The Economic Times & The Free Press Journal’ an English Daily and ‘Maharashtra
Times & Navshakti’ a Regional Daily, on August 14, 2026.
Kindly take the same on record.
Thanking you.
Yours faithfully,
For Bliss GVS Pharma Limited
Aditi Bhatt
Company Secretary
Encl: as above